Table 3.
Diabetes Therapy
| 1992 | 1993 | 1994 | 1995 | 1996 | 1997 | ||
|---|---|---|---|---|---|---|---|
| % patients | EMC | 31.2 | 18.8 | 13.6 | 9.7 | 8.3 | NA |
| diet only | GHC | 24.2 | 24.4 | 23.1 | 22.9 | 21.4 | 18.7 |
| % patients | EMC | 57.0 | 60.2 | 56.0 | 53.5 | 48.8 | NA |
| SU only | GHC | 50.1 | 46.6 | 43.8 | 33.7 | 26.2 | 24.4 |
| % patients | EMC | 1.8 | 2.1 | 1.6 | 1.5 | 1.0 | NA |
| MF only | GHC | 0 | 0 | 0 | 0.7 | 3.1 | 4.7 |
| % patients | EMC | 1.6 | 1.6 | 1.9 | 2.6 | 2.0 | NA |
| INS only | GHC | 20.2 | 22.3 | 25.2 | 25.1 | 23.8 | 24.6 |
| % patients | EMC | 8.2 | 16.4 | 25.0 | 27.5 | 31.7 | NA |
| SU+MF | GHC | 0 | 0 | 0 | 7.7 | 13.6 | 16.3 |
| % patients | EMC | 0 | 0.5 | 0.5 | 4.1 | 5.3 | NA |
| SU+INS | GHC | 5.6 | 6.7 | 7.9 | 5.9 | 5.3 | 5.1 |
| % patients | EMC | 0 | 0 | 0 | 0 | 0 | NA |
| MF+INS | GHC | 0 | 0 | 0 | 2.0 | 4.1 | 3.7 |
| % patients | EMC | 0 | 0.3 | 1.1 | 0.9 | 2.6 | NA |
| SU+MF+INS | GHC | 0 | 0 | 0 | 1.9 | 2.6 | 2.5 |
EMC: ExtraMural Clinic; GHC: Group Health Cooperative; NA: not available; SU: sulfonylureas; MF: metformin; INS: insulin